Resmetirom is one of only two drugs in the pipeline focused on thyroid hormone functions and having good success. Now in a phase 3 trial.
MADRIGAL PRESENTS, Resmetirom a leade... - Living with Fatty...
MADRIGAL PRESENTS, Resmetirom a leader in NAFLD/NASH drug development
Written by
nash2
Partner
To view profiles and participate in discussions please or .
3 Replies
•
Hi Wayne - Loved reading your post. I’m currently in the year long Madrigal Pharmaceuticals phase 3 clinical trial of Resmetirom! I started in the trial October 2020. Of course I don’t know if I’m on placebo or the Resmetirom. I just replied to your email about this a little earlier today. I’m excited about this trial. My next appointment in July is week 40 so I’m over half way through.
Char
Thanks for sharing Wayne. It is really nice knowing that NAFLD/NASH drug development is an active research field 
Hi. Just to say that I am now on that trial. Been on the tablets now for 2 months so a long way to go.Robbo
Not what you're looking for?
You may also like...
Madrigal drug Resmetirom approved by FDA
https://www.fattyliverfoundation.org/a_new_dawn_in_liver_health_fatty_liver_foundation_applauds_brea
The State of NAFLD/NASH Care in America 2023 is Live - We Need Your Voice
Hi community members,
Last year, many of you generously took the time to share your patient...
An invitation to participate in a survey about NASH, and they pay you for your time #NASH
There is a lot of research going on about the patient journey and we have been asked to help the...
Will you take 90 Seconds to Help Improve healthcare for people with NAFLD/NASH? A note from Wayne
First of all, let me thank you in advance for taking this short survey. This may help the patient...
